Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × apatorsen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Squamous Cell Lung Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuronopathy, Distal Hereditary Motor, Type IIB 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 129 Gemcitabine 115 Capecitabine 107 Fluorouracil 99 Paclitaxel 98 Bevacizumab 91 Oxaliplatin 89 Nivolumab 86 Leucovorin 81 Docetaxel 80 Radiosurgery 79 Irinotecan 72 Carboplatin 70 Cisplatin 69 Cetuximab 61 Cyclophosphamide 60 Magnetic Resonance Spectroscopy 59 Specimen Handling 54 Biopsy 53 Radiotherapy 48 Trastuzumab 47 Ipilimumab 44 Drug Therapy 43 Pemetrexed 38 Everolimus 38 Albumin-Bound Paclitaxel 37 130-nm albumin-bound paclitaxel 37 Fulvestrant 36 Doxorubicin 34 aldesleukin 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01844817 2017-05-16

Rainier

SCRI Development Innovations, LLC

Phase 2 Completed

132 enrolled 9 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡